Skip to main content

ND-L02-s0201-005 Phase 2 randomized double blind placebo controlled study to evaluate safety, tolerability, biological activity, and PK of ND-L02-s0201 in subjects with IPF

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Nitto Denko Corporation

Start Date

August 24, 2018

End Date

December 31, 2023
 

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Nitto Denko Corporation

Start Date

August 24, 2018

End Date

December 31, 2023